Cardiology
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology
Genetics
Geriatrics/Aging
Hematology/Oncology
Immunology/Allergy
Infectious Disease
Nephrology
Neurology/Neurosurgery
Obstetrics/Gynecology
Pediatrics
Psychiatry
Public Health, Policy, and Training
Pulmonary
Rheumatology
Surgery

Nejm News Une Mise à Jour The New England Journal of Medicine by Specialties

 


The New England Journal of Medicine: Search Results in Hematology\Oncology
The New England Journal of Medicine (NEJM) RSS feed -- Search Results in Hematology\Oncology. NEJM (http://www.nejm.org) is a weekly general medical journal that publishes new medical research findings, review articles, and editorial opinion on a wide variety of topics of importance to biomedical science and clinical practice.

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
31/12/69 - Ovarian cancer is associated with the highest mortality of all gynecologic cancers in the western world. The majority of patients receive a diagnosis of advanced disease that has spread beyond the ovaries to the peritoneal surface. The most effective treatment for advanced disease involves a…

Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance
31/12/69 - Monoclonal gammopathy of undetermined significance (MGUS) occurs in 3.2% of persons 50 years of age or older and in 5.3% of those 70 years of age or older. MGUS is defined as the presence of a serum monoclonal protein (M protein) at a concentration of 3.0 g per deciliter or less, no monoclonal…

Elimination of Cost Sharing for Screening Mammography in Medicare Advantage Plans
31/12/69 - An extensive body of evidence, including a landmark clinical trial, has shown that cost sharing ? requiring people to pay for health care in the form of a deductible, copayment, or other out-of-pocket expense ? reduces the use of health services. Cost sharing deters the use of effective, but often…

Ovarian Cancer Treatment ? Are We Getting Warmer?
31/12/69 - Regional chemotherapy theoretically results in a decreased rate of systemic toxic effects and a high pharmacologic advantage in tumors that are confined to a single organ or body cavity. However, only in the case of ovarian cancer has such chemotherapy (intraperitoneal chemotherapy) been accepted…

Butterfly Glioma
31/12/69 - Figure 1.

Case 01-2018: A 39-Year-Old Woman with Rapidly Progressive Respiratory Failure
31/12/69 - Presentation of Case. Dr. Raghu R. Chivukula (Medicine): A 39-year-old woman with a history of leukemia and double-unit cord-blood transplantation was admitted to this hospital because of dyspnea, hypoxemia, and the presence of infiltrates in both lungs. Thirty months before this admission, the…

Osimertinib in Untreated EGFR-Mutated Advanced Non?Small-Cell Lung Cancer
31/12/69 - The current standard of care for patients with locally advanced or metastatic non?small-cell lung cancer (NSCLC) harboring epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI)?sensitizing mutations is treatment with a first-generation or second-generation EGFR-TKI such as…

Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
31/12/69 - Immunotherapy enhances a patient?s immune system to fight disease and has recently been a source of promising new cancer treatments. Among the many immunotherapeutic strategies, immune checkpoint blockade has shown remarkable benefit in the treatment of a range of cancer types. Immune checkpoint…

Osimertinib as First-Line Treatment in EGFR-Mutated Non?Small-Cell Lung Cancer
31/12/69 - Genetic analysis is now routine in metastatic non?small-cell lung cancer (NSCLC) to identify somatic sensitizing mutations in EGFR, typically L858R and exon 19 deletion (Ex19del). Patients with these genotypes are treated with first- or second-generation epidermal growth factor receptor tyrosine…

Going from A to Z
31/12/69 - Foreword. In this Journal feature, information about a real patient is presented in stages (boldface type) to an expert clinician, who responds to the information, sharing his or her reasoning with the reader (regular type). The authors? commentary follows. Stage. A 70-year-old man presented to the…

Copyright © 2004/2011 Health.Cat

Annuaire de Sante | S'inscrire au MedSante  | Dictionnaire medicale  Forumed des médecins